Sorrento Therapeutics (SRNE)
(Delayed Data from OTC)
$0.01 USD
0.00 (-22.07%)
Updated May 31, 2024 03:53 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Sorrento Therapeutics, Inc. [SRNE]
Reports for Purchase
Showing records 61 - 80 ( 186 total )
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: A PolyClonal Cocktail R-D Day Scheduled
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: Regarding Henry, We Spoke with the CEO
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: White House Briefing Mentions a mAb Therapy at 70%
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: STI-1499 Begins Phase 1 in COVID Could Lead to an EUA by Year?s End
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: Did You Hear the News? COVI-TRACK on TRACK
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY- Steady Progress - IND Filed, Merger Signed
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Rapid Detection Test Possible Game-Changer; Reiterate Buy; Raising PT to $30
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: COVI-TRACE - A Self-Contained 30-Minute Saliva Test
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Abivertinib Cleared to Advance Into COVID-19 Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: A Novel TKI Jumps to Phase 2 in COVID Patients to Shut Down the Cytokine Storm
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Vaccine Progress; Antibody Test Launches Imminent; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: Viva Sorrento! 100 Million Doses Per Month
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVI-TRACK Antibody Test Emergency Use Authorization Application Submitted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVIDTRAP Preclinical Progress; BTK Inhibition Applicability in COVID-19; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
FDA Clearance Received for STI-6129 Phase 1 Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Novel Kinase Inhibitor Licensed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
STI-1499 Blocks SARS-CoV-2 Host Cell Infection; 1Q20 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Antibody Cocktail Collaboration Established to Combat COVID-19; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Natural Killer Cell Therapy Moves Ahead; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R